GOLDMAN SACHS GROUP INC - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 54 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$67,276
-51.7%
13,322
-51.9%
0.00%
Q2 2023$139,321
-73.4%
27,698
-67.5%
0.00%
Q1 2023$523,802
+184.7%
85,171
+186.3%
0.00%
Q1 2022$184,000
-28.4%
29,752
-6.3%
0.00%
Q4 2021$257,000
+51.2%
31,762
+178.7%
0.00%
Q3 2021$170,000
+78.9%
11,395
-45.4%
0.00%
Q1 2021$95,000
+126.2%
20,867
+6.5%
0.00%
Q4 2020$42,00019,6000.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q2 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 117,242$311,0000.07%
Andesa Financial Management Inc. 16,655$44,0000.04%
Sofinnova Investments, Inc. 142,635$378,0000.03%
INSPIRION WEALTH ADVISORS, LLC 22,875$61,0000.02%
REGENTATLANTIC CAPITAL LLC 15,753$42,0000.00%
Ellis Investment Partners, LLC 2,250$5,0000.00%
tru Independence LLC 500$00.00%
Renaissance Technologies 120,269$319,0000.00%
D. E. Shaw & Co., Inc. 13,281$35,0000.00%
VANGUARD GROUP INC 36,206$96,0000.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders